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Amyloid Fibril Nucleation: Effect of Amino Acid Hydrophobicity 
 
ABSTRACT 
We consider the nucleation of amyloid fibrils when the process occurs by direct 
polymerization of fully extended peptides (i.e. β-strands) into fibrils composed of 
successively layered β-sheets with alternating weak and strong hydrophobic surfaces. We 
extend our recently developed nucleation model (Kashchiev, D.; Cabriolu, R.; Auer, S. J. 
Am. Chem. Soc. 2013, 135, 1531-1539) to derive general expressions for the work to form 
such fibrils, the fibril solubility, the nucleation work, the equilibrium concentration of 
nuclei, and the fibril nucleation rate as explicit functions of the supersaturation of the 
protein solution. Analysis of these expressions illustrates the effect of increased 
asymmetry between the weak and strong hydrophobic β-sheet surfaces on the 
thermodynamics and kinetics of the polymerization process. In particular, the application 
of our theoretical framework to a simple model peptide system shows that lowering the 
hydrophobicity of one β-sheet surface can hamper protein fibrillation, because the 
threshold concentration below which the fibril nucleation is practically arrested, and 
above which the process occurs vigorously, because then each monomer in the solution 
acts as a fibril nucleus, is shifted to higher concentrations. This effect is entirely due to the 
effect of asymmetry of the two hydrophobic β-sheet surfaces on the fibril solubility. In 
addition, with increasing asymmetry the nucleation rate of one fibril polymorph becomes 
increasingly dominant, illustrating that there is a morphological selection between the two 
possible polymorphs.  
KEYWORDS 
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INTRODUCTION 
Proteins seem to have an intrinsic tendency to assemble into highly ordered fibrillar 
aggregates including amyloid fibrils which are associated with various neurodegenerative 
disorders such as Alzheimer’s and Parkinson’s diseases (e.g., refs 
1,2
). Structural studies 
(e.g., refs. 
3-5
) have shown that amyloid fibrils share a common cross-β structure formed 
by intertwined layers of β-sheets extending in a direction parallel to the fibril axis. The 
formation of such amyloid fibrils requires strong molecular interactions between the 
proteins with a preference in direction of the fibril axis.
6
 This might be attributed to the 
strongly directional protein backbone hydrogen bonding that enables β-strands to 
assemble into β-sheets arranged parallel to the fibril axis, and to the weaker side-chain 
side-chain interactions that cause the fibril to thicken and to form protofilaments.
7
 The 
strength of such bonds depends (among other factors) on the side-chain hydrophobicity of 
the amino acids in the β-strand. As the orientation of side-chains within a β-strand 
alternates (they successively orient along the positive and negative direction of the fibril 
thickening axis), the hydrophobicity of the two surfaces of a β-sheet is generally different, 
except for homo-polypeptides when all amino acids within a β-strand are composed of the 
same type of amino acid. In this article we address the question about how does an 
asymmetry in the hydrophobicity of the two β-sheet surfaces affect the thermodynamics 
and the kinetics of amyloid fibril nucleation? 
 The nucleation of amyloid fibrils refers to the process of random 
generation of such nanofibrils that have the ability to irreversibly grow. Unless the 
nanofibril size exceeds the size n* of the fibril nucleus, the nanofibril is more likely to 
dissolve than to grow (here n* is the number of peptide monomers in the fibril nucleus). 
In classical nucleation theory (CNT) (e.g., refs 
8,9
), at a given supersaturation the nucleus 
size n* has a unique value that can be obtained from thermodynamic considerations of the 
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energy gained when n* monomers in a supersaturated solution assemble into the nucleus, 
and the work needed to create the nucleus surface. Our recent simulations revealed,
10
 
however, that the strong interaction anisotropy that characterizes amyloid fibrils leads to a 
peculiar kind of nucleation not entirely complying with the paradigm of standard 
nucleation theory. The simulations showed that amyloid fibril nuclei are actually 
aggregates with ambiguous dimensionality, and the work on creating the nucleus/solution 
interface does not scale in a definite way with the nucleus size (in CNT this work scales 
as n*2/3 for 3D nuclei and as n*1/2  for 2D nuclei).
9
 As a consequence, at a given 
supersaturation the size n* does not have a unique value and amyloid nanofibrils of 
different size and shape can act as fibril nuclei. This called for a reconsideration of the 
theoretical description of amyloid fibril nucleation presented elsewhere,
11-13
 and a new 
theoretical approach
14
 provided a remarkably good agreement with the simulation data
10
 
for the nucleation of nanosized amyloid fibril composed of successively layered β-sheets 
with surfaces symmetric (i.e. equivalent) with respect to their hydrophobicity. The 
objective of this article is to extend our new nucleation model
14
 to address the question 
about the effect that the asymmetry in the hydrophobicity of the two β-sheet surfaces can 
have on the thermodynamics and the kinetics of amyloid fibril nucleation. 
The usefulness of the derived general expressions for the fibril nucleation rate J as 
an explicit function of the supersaturation s is twofold. First, they are a first step towards 
first-principle predictions of fibril nucleation rates based on the amino acid sequence of 
the proteins. Although existing models based on protein physiochemical properties are 
able to predict changes in aggregation propensities, they cannot provide information about 
the fibril nucleation barrier and rate (e.g. refs 
15-18
). Second, understanding the J(s) 
dependence of such fibrils is an indispensible ingredient in the set of rate equations 
describing the overall kinetics of unseeded amyloid fibrillation (see e.g. refs 
19-21
). 
! 5 
 
THEORETICAL METHODS 
 
Model. For describing the arrangement of virtually fully extended β-strands in a 
nanosized amyloid fibril (protofilament) of successively layered β-sheets with alternating 
weakly hydrophobic (WH) and strongly hydrophobic (SH) surfaces (Figure 1), we extend 
our recently developed lattice model.
12
 Each β-strand (a segment of a protein chain 
composed of several amino acids) is represented by a right rectangular prism. Due to their 
strong hydrogen bonds, the β-strands can arrange themselves laterally into β-sheets. The 
sheets consist of different number m of β-strands ( ,...3,2,1=m ) and are parallel to the 
fibril lengthening axis (the m axis in Figure 1). Along its thickening axis (the i axis in 
Figure 1), the fibril is built up of i β-sheets ( ,...3,2,1=i ) which are held together by e.g. 
relatively weak hydrophobicity-mediated bonds between the β-strands.7 The strength of 
such bonds depends on the side-chain hydrophobicity of the amino acids in the β-strand. 
As the orientation of side-chains within a β-strand alternates (they successively orient 
along the positive and negative direction of the m axis), the hydrophobicity of the two 
surfaces of a β-sheet is generally different, except for the case when all amino acids 
within a β-strand are identical. Since the fibril width is fixed and equal to the β-strand 
length, the fibril can be considered as a 2D aggregate in the m,i plane, with building 
blocks (the β-strands) arranged in a 2D lattice with simple rectangular symmetry (Figure 
1). The areas occupied by a β-strand at the fibril faces perpendicular to the m and i axes 
are a (m
2
) and ah (m
2
), respectively, and the area occupied by the β-strand in the m,i plane 
is a0 (m
2
) (Figure 1). These areas are given by dda
h
=
0
, dda
0
=  and 
hh
dda
0
= , where 
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dh (m) is the distance between the β-strands in a β-sheet, d (m) is the intersheet distance in 
the fibril, and d0 (m) is the β-strand length, i.e. the β-sheet width. 
The ontogenesis of the smallest (nanosized) amyloid fibrils in the m,i plane can be 
described by 2D crystal nucleation and growth theories.
8,9
 Essential parameters in these 
theories are the specific surface energies of the different crystal faces. In our model for 
amyloid fibril nucleation, three of the four fibril specific surface energies are of 
immediate importance: the first one is the specific surface energy σ  (J/m
2
) of the fibril 
face perpendicular to the m axis, the second and third one are the strong and weak specific 
surface energy σ
s
 (J/m
2
) and σ
w
 (J/m
2
) of the fibril faces perpendicular to the i axis, 
respectively. The fourth fibril specific surface energy, σ
0
 (J/m
2
), characterizes the fibril 
face parallel to the m,i plane and enters only implicitly, via the supersaturation, the 
description of the fibril energetics.
11
 To a first approximation, the surface energy is 
proportional to the energy of the broken bonds at the respective surface
 
and, for that 
reason, σ , σ
s
, and σ
w
 are largely determined by the strength of the bonds between the 
neighboring β-strands in the fibril. As fibril elongation is primarily driven by the 
formation of strong hydrogen bonds between the β-strands along the m axis, and fibril 
thickening along the i axis is due to the much weaker bonds between the β-strands arising, 
e.g., from the hydrophobic effect, for the amyloid fibrils we have the important inequality 
σ >>σ
s
,  σ
w
.
 
For the analysis to follow, we introduce the dimensionless specific surface 
energies ψ  and ψ
w
, ψ
s
 of the fibril faces perpendicular to the m axis and the i axis, 
respectively, which are given by 
ψ = aσ / kT = E / 2kT         (1) 
ψ
s
= a
h
σ
s
/ kT = E
s
/ 2kT        (2) 
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ψ
w
= a
h
σ
w
/ kT = E
w
/ 2kT        (3) 
where k is the Boltzmann constant and T (K) is the absolute temperature. The second 
equality in eqs 1 to 3 result from using the approximate relation
12
 σ = E / 2kT  between σ 
and the binding energy E of the bond between two nearest-neighbor β-strands in a β-
sheet, as well as the approximate relation σ
s
= E
s
/ 2kT  (or σ
w
= E
w
/ 2kT ) between σs  
(or σw) and the strong (or weak) hydrophobicity-mediated binding energy Es  (or Ew) of 
two nearest-neighbor β-strands in adjacent β-sheets.  
Importantly, the dimensionless specific surface energy ψ  perpendicular to the m 
axis can contain contributions from both nearest-neighbor hydrogen bonding and 
hydrophobicity-mediated bonds and is given by ψ =ψ
hb
+ c
s
ψ
s
+ c
w
ψ
w
. Here ψ
hb
 is the 
dimensionless specific surface energy due to hydrogen bonding and cs, cw are parameters 
determining the contributions of hydrophobicity-mediated bonds to ψ . For most of our 
illustrations we either set c
s
= c
w
= 0 , which means that there is no hydrophobic 
contribution to ψ , or we set c
s
= c
w
= 0.5  as in our previous work.
22
      
 
RESULTS AND DISCUSSION 
 
Nucleation Work. According to atomistic nucleation theory,12 an n-sized nanofibril 
composed of i β-sheets forms by a layer-by-layer nucleation mechanism. First, a 1β-sheet 
forms which at a transition size nt changes its shape to that of a 2β-sheet with a partially 
or fully built-up second β-sheet on one of its two sides. The so-formed 2β-sheet lengthens 
further by attachment of β-strands to the fibril ends till a second transition size nt is 
reached, at which the 2β-sheet changes its shape to that of a 3β-sheet with again a 
partially or fully built-up third β-sheet on one of its two sides. This process continues till 
! 8 
the n-sized nanofibril is composed of i β-sheets (see the schematic illustration of 
nanofibrils in Figure 2a). In our model (Figure 1) we assume that for a 1β-sheet the SH 
surface is always on top (indicated by the red line) whereas the WH surface is at the 
bottom (indicated by the blue line). In addition, a β-strand can only bind itself to a WH β-
sheet surface with its WH side, and to an SH β-sheet surface with its SH side. 
Consequently, the hydrophobicity of the surface of a nanofibril alternates with increasing 
number of layers. 
In order to write down a formula for the dimensionaless work w for nanofibril 
formation, we need to consider two different cases. The first is the formation of a fibril 
with an odd number i of β-sheets which, because of the assumed growth mechanism 
described above, always has one WH and one SH surface. Then w for sizes n =1,  2,...,  n
t
, 
can be written down as ( i =1,3, 5,... ) 
inisniw
sw
ψψψ 2]/)([),( ++−−=
      
(4) 
where s is the dimensionless supersaturation. The second case is the formation of a fibril 
with an even number i of β-sheets that can have either two WH or two SH surfaces. Then 
w for n =1,  2,...,  n
t
, can be written down as ( i = 2, 4, 6,... ) 
w(i,n) = −(s− 2ψ
w
/ i)n+ 2ψi        (5) 
w(i,n) = −(s− 2ψ
s
/ i)n+ 2ψi
 
       (6) 
for a fibril with two WH or two SH surfaces, respectively. In eqs 4, 5 and 6 the term –sn 
is the energy gained by assembling n monomers from the solution into an n-size 
nanofibril, and the ψ
w
,  ψ
s
and ψ  terms represent the work done on creating the total 
surface area of a nanofibril with the shape of an iβ-sheet without a β-strand on one of its 
two hydrophobic sides (in this case the nanofibril length m = n / i  is the same for all iβ-
sheets). 
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In order to write down formula for w for n = n
t
+1,  n
t
+ 2,...,  n
t
+m
t
 
(where inm
tt
/=  is the number of β-strands in any of the i equally long β-sheets 
constituting the iβ-sheet-shaped nanofibril when the first β-strand of the subsequent β-
sheet is attached to the nanofibril), we first consider the case of an iβ-sheet with an odd 
number of β-sheets (with one WH surface and one SH surface) that transforms into an 
(i+1)β-sheet where the new β-sheet forms by β-strand binding to the iβ-sheet’s either WH 
or SH side. Then w is given by  ( i =1,3, 5,... )  
)1(2)()]([),( ++−+−−++−= iimnimnmmsnniw
tsttwts
ψψψψ
  
(7) 
)1(2)()]([),( ++−+−−++−= iimnimnmmsnniw
twttstw
ψψψψ   (8) 
for the binding to the WH or SH side, respectively. In eqs 7 and 8, the third and fourth 
terms on the right side describe the change in the surface energy when the β-strands of the 
subsequent β-sheet attach to the WH or SH side of the nanofibril, respectively (the term 
( n− im
t
) is the number of β-strands in the subsequent layer). When a new layer forms, the 
hydrophobicity of the surface of a nanofibril changes from weak to strong (or strong to 
weak), see Fig. 1. In the second case, an iβ-sheet composed of an even number of layers 
(with two either WH or SH surfaces) transforms into an (i+1)β-sheet where the new β-
sheet forms by β-strand binding to one of the iβ-sheet two either WH or SH sides. Then w 
is given by  ( i = 2, 4, 6,... )   
)1(2)()]([),( ++−+−−++−= iimnimnmmsnniw
tsttwtw
ψψψψ
  
(9) 
)1(2)()]([),( ++−+−−++−= iimnimnmmsnniw
twttsts
ψψψψ   (10) 
for the binding to a WH or SH side, respectively. 
Figure 2 displays the n dependence of w from eqs 4 to 10 for nanofibril formation 
with exemplifying transition sizes n
t
=12 , 64, 144, 240. The lines are drawn with 
c
s
= c
w
= 0  at ψ =10 , ψ
s
=1  for ψ
w
=1 , 0.7, and 0.1, i.e. at three different ratios 
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ψ
w
/ψ
s
=1, 0.7 and 0.1 of the nanofibril hydrophobicity asymmetry. As seen in Figure 2a 
for the symmetric case (ψ
w
/ψ
s
=1), at s = 0.7ψ
s
, according to eq 4, w for a single β-sheet 
( i =1 ) increases linearly till n reaches the exemplifying transition size n
t
=12  
corresponding to transition length m
t
=12 ). The transformation from a 1β-sheet to a 1β-
sheet plus one β-strand on top of it, corresponds to a sharp increase of w between n =12  
and 13. After this shape transformation, according to eq 7, w diminishes linearly with n up 
to n = n
t
+m
t
= 24 . At this size, the nanofibril is composed of two equally long β-sheets 
and, according to eq 5, w for further elongation increases linearly again till the next 
exemplifying transition size n
t
= 64 . The transformation from a 2β-sheet to a 2β-sheet 
plus one β-strand on top of it, corresponds to a sharp increase of w between n = 64  and 
65. After this shape transformation, according to eq 9, w diminishes linearly with n up to 
n = n
t
+m
t
= 96 . After this size, the 3β-sheet can elongate unlimitedly, because at 
s = 0.7ψ
s
, according to eq 4, the work w(3,n)  also decreases with n. In standard 
nucleation theory, the nanofibril of size n*= n
t
+1= 65 , which requires the maximum 
formation work, is the fibril nucleus. 
The case of weak hydrophobicity asymmetry is illustrated in Figure 2b at 
ψ
w
/ψ
s
= 0.7  and s = 0.6ψ
s
. As before, according to eq 4, w for a single β-sheet ( i =1) 
increases linearly till n reaches the exemplifying transition size n
t
=12  corresponding to 
m
t
=12 . The sharp increase of w between n =12  and 13 now depends on whether the 1β-
sheet transforms into a 1β-sheet plus one β-strand on top or on bottom of the sheet. 
Binding of a β-strand with its SH side on top requires less work than binding of a β-strand 
with its WH side on bottom. Although the difference in w is small at n = n
t
+1=13 , 
according to eqs 7 and 8, it does increase as w diminishes linearly with n (with different 
! 11 
slopes) up to n = n
t
+m
t
= 24 , till the second β-sheet is fully formed. At this size, the 
nanofibril is composed of two equally long β-sheets with two either SH or WH surfaces. 
According to eqs 5 and 6, during further nanofibril elongation w increases linearly with 
different slopes till the next exemplifying transition size n
t
= 64 , as it requires more work 
to form a fibril with two SH surfaces than a fibril with two WH ones. There is a sharp 
increase of w between n = 64  and 65, when the 2β-sheet (with two either WH or SH 
sides) transforms into a 2β-sheet plus one β-strand attached either on top or on bottom, 
and according to eqs 9 and 10, w diminishes linearly (with different slopes) with n up to 
n = n
t
+m
t
= 96 . The 3β-sheets formed along these two different pathways are now 
energetically identical as they both have the same fibril structure with one WH and one 
SH surface. The 3β-sheet can elongate unlimitedly, because according to eq 4, at 
s = 0.6ψ
s
, the work w(3,n)  also decreases with n. In this case, the nanofibril of size 
n*= n
t
+1= 65 , which requires the maximum formation work, is also the fibril nucleus. 
The w(n)  dependence for the strongly asymmetric case, with ψ
w
/ψ
s
= 0.1  at 
s = 0.12ψ
s
, is illustrated in Figure 2c. The differences in w when fibrils with two SH or 
two WH surfaces form is now more pronounced. As can be seen in the figure, at the 
choosen s value, according to eq 5, w(2,n)  decreases with n for a fully formed 2β-sheet 
with two WH surfaces and it can elongate unlimitedly. In contrast, according to eq 6, 
w(2,n)  increases with n for a fully formed 2β-sheet with two SH surfaces. Furthermore, 
according to eq 4, w(3,n)  for a fully formed 3β-sheet also increases with n. Similarly, a 
fully formed 4β-sheet with two WH surfaces can elongate unlimitedly, whereas w(4,n)  
for a 4β-sheet with two SH surfaces, and w(5,n)  for a fully formed 5β-sheet increases 
with n. This implies that in a protein solution under such conditions preferably 2β-sheets 
! 12 
with two WH surfaces nucleate and grow, because 2β-sheets with two SH surfaces and 
3β-sheets dissolve. The growing 2β-sheets can transform into a 4β-sheet with again two 
WH surfaces, but for this to happen a potentially high nucleation barrier needs to be 
overcome (see Figure 2c).  
The transformation of fibrils from 2β-sheets to 4β-sheets, and 4β-sheets to 6β-
sheets was reported by Irbäck et al.
23
 observed in Monte Carlo simulations of essentially 
the same model peptide system. The underlying physical reason for such a behaviour is 
that increasing the hydrophobicity asymmetry of β-sheet surfaces can make iβ-sheets less 
soluble than (i+1) β-sheets, i.e. thinner nanofibrils are less soluble than thicker ones, 
which cannot be the case for the symmetric case (see e.g. the simulations by Zhang et al.
24
 
on the nucleation and elongation of amyloid fibrils). This will be discussed in the 
following section.   
 
Fibril Solubility. The coexistence supersaturations s
iβ  at which fibrils of fixed thickness 
of i β-sheets coexist with the protein solution are readily obtained by setting equal to zero 
the bracketed factor in eqs 4 to 6 because this factor is the driving force for fibril growth 
or dissolution. This is so, because at these s
iβ values w(i,n)  at fixed i does not change 
with n. Doing that leads to the formulas ( i =1,3, 5,... ) 
s
iβ = (ψw +ψs ) / i         (11) 
for iβ-sheets with an odd number of layers and ( i = 2, 4, 6,... ) 
s
iβ ,w = 2ψw / i          (12) 
s
iβ ,s = 2ψs / i          (13) 
for iβ-sheets with an even number of β-sheets with two either WH or SH surfaces, 
respectively. For the symmetric case ( ψ
w
/ψ
s
=1 ), the above equations yield 
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s
iβ = siβ ,w = siβ ,s = 2ψs / i , i.e. then the coexistence supersaturations for the fibrils of 
thickness i =1, 2, 3, and 4 are given by s
iβ = 2 , 1, 2/3, and 1/2, respectively. As indicated 
in Figure 3a, the s > s
1β = 2  range (range i = 0  in the figure) corresponds to the 
metanucleation regime in which each β-strand in the solution acts as a fibril nucleus. 
Similarly, when s > s
2β =1 , the 2β-sheets can lengthen irreversibly. Thus, in the 
s
2β < s < s1β range (range i =1  in the figure), 1β-sheets tend to dissolve and the fibril 
nucleus is a 1β-sheet plus one β-strand attached to one of its two sides. The situation is 
analogous in the s
3β < s < s2β  range (range i = 2 ) and the s4β < s < s3β  range (range i = 3 ) 
where the fibril nucleus is a 2β-sheet plus one β-strand attached sidewise and a 3β-sheet 
plus one β-strand attached sidewise, respectivley. 
For the weakly asymmetric case (Figure 3b), ψ
w
/ψ
s
= 0.7 , the coexistence 
supersaturations for iβ-sheets of thickness i =1 and 3 are obtained from eq 11 and are 
s
iβ =1.7  and 0.57, respectively. The coexistence supersaturations for the fibrils of 
thickness i = 2  and 4 with two WH surfaces are obtained from eq 12 and are s
iβw = 0.7  
and 0.35, respectively. Similarly, for fibrils with two SH surfaces, they are given by eq 13 
and are s
iβs =1  and 0.5, respectively. At this weak asymmetry, there exists a hierarchy of 
the coexistence supersaturations, s
4βw < s4βs < s3β < s2βw < s2βs < s1β , such that iβ-sheets are 
more soluble than (i+1)β-sheets. As indicated in Figure 3b, the s > s
1β =1.7  range (white 
area) corresponds to the metanucleation regime in which each β-strand in the solution acts 
as a fibril nucleus. When s > s
2βs =1, the 2β-sheets with two either WH or two SH 
surfaces can lengthen irreversibly, and in the s
2βs < s < s1β  range (orange area) the 1β-
sheet plus one β-strand attached to either side is a fibril nucleus. The situation changes 
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when s > s
2βw = 0.7 , as then only the 2β-sheets with two WH surfaces can lengthen 
irreversibly, whereas the one with two SH surfaces dissolves. Thus, in the 
s
2βw < s < s2βs range (yellow area) the 1β-sheet plus one β-strand attached to the β-sheet 
SH side is the fibril nucleus. In addition, we need to consider that in this supersaturation 
range also 3β-sheets can nucleate (although with a low rate) where the fibril nucleus is a 
2β-sheet with two SH sides plus one β-strand attached sidewise is a fibril nucleus. When 
s > s
3β = 0.57 , the 3β-sheet can lengthen irreversibly, and in the s3β < s < s2βw  range 
(green area) the 2β-sheet with two either WH or SH surfaces plus one β-strand attached 
sidewise is the fibril nucleus. The situation when s > s
4βs = 0.5  is analogous to the one 
when s > s
2βs , and the situation when s > s4βw = 0.35  is analogous to the one when 
s > s
2βw . 
For the strongly asymmetric case (Figure 3c), ψ
w
/ψ
s
= 0.1 , the coexistence 
supersaturations for the fibrils of thickness i =1 and 3 are also given by eq 11 and are 
s
iβ =1.1  and 0.37, respectively. The coexistence supersaturations for the fibrils of 
thickness i = 2  and 4 with two WH surfaces are given by eq 12 and are s
iβw = 0.1  and 
0.05, respectively, and with two SH surfaces they are given by eq 13 and are s
iβs =1  and 
0.5, respectively. At this strong asymmetry, the hierarchy of the coexistence 
supersaturations, s
4βw < s2βw < s3β < s4βs < s2βs < s1β , is such that iβ-sheets can be less 
soluble than (i+1)β-sheets. In particular, a 2β-sheet with two WH surfaces is less soluble 
than a 3β-sheet and a 4β-sheet with two SH surfaces. As can be seen in Figure 3c, 
although the threshold supersaturations have been shifted to lower values, for 
s > s
3β = 0.37  
the situation is analogous to that of the weakly asymmetric case, in the 
sense that the fibril nuclei are the same in the white, orange and yellow s ranges. When 
! 15 
s > s
2βw = 0.1 , however, a 2β-sheet and a 4β-sheet both with two WH surfaces can 
lengthen irreversibly. Thus, in the s
2βw < s < s3β  
range (green area) the 1β-sheet plus one 
β-strand attached to the sheet SH side and the 3β-sheet plus one β-strand attached to the 
sheet SH side are the fibril nuclei. In this asymmetry ratio, s
4βs = 0.5  (indicated by the 
dashed line) does not play a role. When s > s
4βw = 0.05 , the 4β-sheets with two WH 
surfaces can lengthen irreversibly, and in the s
4βw < s < s2βw  range (grey area) the 3β-sheet 
plus one β-strand attached to the SH side is the fibril nucleus. 
The threshold value of the asymmetry ratio above which there exists a hierarchy of 
the coexistence supersaturations, i.e. s
4βw < s4βs < s3β < s2βw < s2βs < s1β , where a (i+1)β-
sheet is less soluble than a iβ-sheet, is of practical relevance, as it allows to preferably 
nucleate and grow fibrils with a particular morphology, i.e. 2β-sheets with two weak 
hydrophobic surfaces (see section Nucleation Work). This threshold value can readily be 
obtained by setting equal the coexistence supersaturations 
w
s β2  and β3s  from eqs 11 and 
12, which gives ψ
w
/ψ
s
= 0.5 . 
 
Length Distribution of Nuclei. According to CNT in its self-consistent formulation, 
the equilibrium concentration C
m
t
*  of nuclei is given by the Boltzmann-type formula 
C
m
t
*
=C
1
e
w(1,1)−w* , where w(1,1)  is the dimensionless work to form the smallest nanofibril 
of one β-strand and w*≡ w(i,n*)  is the dimensionless nucleation work. From eq 4 we 
have w(1,1) = −s+ψ
s
+ψ
w
+ 2ψ . Setting n = n*  and using n*= n
t
+1= im
t
+1  in the eqs 7 
and 8, we obtain the following general formulas for the nucleation work of fibril nuclei 
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composed of an odd number of iβ-sheets plus one β-strand attached to its SH ( i =1,  3, 5, 
…; m
t
=1 , 2, 3, …; 2ψ
w
/ (i+1)< s < (ψ
s
+ψ
w
) / i ): 
w*= (ψ
w
+ψ
s
− is)m
t
−ψ
s
+ψ
w
− s+ 2ψ(i+1)      (14) 
or WH ( i =1,  3, 5, …; m
t
=1 , 2, 3, …; 2ψ
s
/ (i+1)< s < (ψ
s
+ψ
w
) / i ): 
w*= (ψ
w
+ψ
s
− is)m
t
−ψ
w
+ψ
s
− s+ 2ψ(i+1)      (15) 
side. Similarily, from eqs 9 and 10 we obtain the nucleation work for fibril nuclei with an 
even number of iβ-sheets plus one β-strand attached to either one of the β-sheet two WH 
( i = 2,  4, 6, …; m
t
=1 , 2, 3, …; (ψ
s
+ψ
w
) / (i+1)< s < 2ψ
w
/ i ): 
w*= (2ψ
w
− is)m
t
−ψ
w
+ψ
s
− s+ 2ψ(i+1)      (16) 
or two SH ( i = 2,  4, 6, …; m
t
=1 , 2, 3, …; (ψ
s
+ψ
w
) / (i+1)< s < 2ψ
s
/ i ): 
w*= (2ψ
s
− is)m
t
−ψ
s
+ψ
w
− s+ 2ψ(i+1)      (17) 
sides. Using w(1,1)  from above, and eqs 14 to 17, we now obtain the corresponding 
formulas for the equilibrium concentration of fibril nuclei composed of an odd number of 
iβ-sheets plus one β-strand attached to the β-sheet WH ( i =1,  3, 5, …; m
t
=1 , 2, 3, …; 
2ψ
s
/ (i+1)< s < (ψ
s
+ψ
w
) / i ): 
C
m
t
*
=m
t
C
1
e
is−(ψ
w
+ψ
s
)[ ]mt−2ψi+2ψw        (18) 
or SH ( i =1,  3, 5, …; m
t
=1 , 2, 3, …; 2ψ
w
/ (i+1)< s < (ψ
s
+ψ
w
) / i ): 
C
m
t
*
=m
t
C
1
e
is−(ψ
w
+ψ
s
)[ ]mt−2ψi+2ψs        (19) 
side, and ( i = 2,  4, 6, …; m
t
=1 , 2, 3, …; (ψ
s
+ψ
w
) / (i+1)< s < 2ψ
s
/ i ): 
C
m
t
*
= 2m
t
C
1
e
is−2ψ
w[ ]mt−2ψi+2ψw        (20) 
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for fibril nuclei with an even number of iβ-sheets plus one β-strand attached to either one 
of the β-sheet two WH sides or ( i = 2,  4, 6, …; m
t
=1 , 2, 3, …; 
(ψ
s
+ψ
w
) / (i+1)< s < 2ψ
s
/ i ): 
C
m
t
*
= 2m
t
C
1
e
is−2ψ
s[ ]mt−2ψi+2ψs        (21) 
when the β-strand attached to either one of the β-sheet two either SH sides. The factors 
m
t
 and 2m
t
 in these expressions take into account the fact that the β-strand can attach 
itself to m
t
 or 2m
t
 equivalent sites. Figure 4 displays C
m
t
*  from eqs 18 and 19 at ψ =10 , 
ψ
s
=1 , ψ
w
= 0.7 and s /ψ
s
=1.2  and 1.6 (as indicated). As can be seen from the figure, 
there exists a broad distribution of transition lengths m
t
 at which a 1β-sheet transforms 
into a 2β-sheet. Also, C
m
t
*  passes through a maximum at m
t
=m
t
* . We note that the length 
m
t
=m
t
*  of the most numerous nuclei and their concentration C
m
t
*
*  can easily be calculated 
from the condition for maximum of C
m
t
*
*  but we do not show the formulas here. As 
already mentioned earlier, such a distribution is in contrast to CNT, which assumes that 
the nucleus has a uniquely defined size. The concentration of fibril nuclei with thickness 
of one β-sheet plus one β-strand attached to the β-sheet SH side is higher than that when 
the β-strand is attached to the β-sheet WH side, whereas m
t
*  is similar for both cases. 
Increasing s shifts m
t
*
 to larger sizes and broadens the distribution.  
In order to calculate the fibril nucleation rate we need to know the total 
concentration C*= C
m
t
*
m
t
=1
∞
∑  of nuclei of all lengths. From eqs 18 to 21, with the aid of 
the exact formula px p = x / (1− x)2
p=1
∞
∑ , it follows that C *  is given by ( i =1,  3, 5, …; 
m
t
=1 , 2, 3, …; 2ψ
w
/ (i+1)< s < (ψ
s
+ψ
w
) / i ): 
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C*=C
1
e
i(s−2ψ )−ψw+ψs / (1− e
is−(ψw+ψs ))
2       (22) 
for fibril nuclei composed of an odd number of β-sheets plus one β-strand attached to the 
β-sheet SH or ( i =1,  3, 5, …; m
t
=1 , 2, 3, …; 2ψ
s
/ (i+1)< s < (ψ
s
+ψ
w
) / i ): 
C*=C
1
e
i(s−2ψ )−ψs+ψw / (1− e
is−(ψw+ψs ))
2       (23) 
two WH side, respectively, and by ( i = 2,  4, 6, …; m
t
=1 , 2, 3, …; 
(ψ
s
+ψ
w
) / (i+1)< s < 2ψ
s
/ i ): 
C*= 2C
1
e
i(s−2ψ )
/ (1− e
is−2ψw )
2        (24) 
for fibril nuclei with an even number of β-sheets plus one β-strand attached to either one 
of the β-sheet two WH or ( i = 2,  4, 6, …; m
t
=1 , 2, 3, …; (ψ
s
+ψ
w
) / (i+1)< s < 2ψ
w
/ i ): 
C*= 2C
1
e
i(s−2ψ )
/ (1− e
is−2ψ
s )
2        (25) 
two SH sides. 
 
Nucleation Rate. The fibril nucleation rate J (m-3 s-1) is the frequency of appearance of 
supernucleus fibrils per unit solution volume. We first determine J in the metanucleation 
range s >ψ
w
+ψ
s
 in which there is no nucleation barrier for fibril formation and a single 
β-strand in the solution is the fibril nucleus. Then J is the net number f
1
− g
2
 of monomers 
that attach per unit time to one of the two strong bonding sides of a monomer 
( s >ψ
w
+ψ
s
) (ref 
14
) 
J = ( f
1
− g
2
)C
1
         (26) 
Here the monomer-to-monomer attachment frequency f
1
= 2ka is twice the frequency ka  
(s
-1
) of monomer attachment to one of the two strong-bond sides of a monomer (Figure 
5a), and the detachment frequency g
2
= 2kd  is twice the frequency kd  (s
-1
) of monomer 
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detachment from one of the two strong-bond sides of a monomer (Figure 5b). Here k
a
 is 
expected to increase exponentially with s according to (ref 
10
)
 
k
a
(s) = k
e
e
s          (27) 
where k
e
 is the value of k
a
 at equilibrium (then 0=s ). In order to obtain an expression 
for the frequency of monomer detachment from one of the two strong-bond sides of a 
monomer, we derive a general expression for the detachment frequency k
d
(b,b
w
,b
s
)  of a 
monomer from the fibril periphery. As known from Boltzmann statistics, the probability 
for transition from an initial to a final state decreases exponentially with the work spent 
on the transition. The detachment of a peripheral monomer requires the work 
2bψ + 2b
w
ψ
w
+ 2b
s
ψ
s
, if the detaching β-strand is bound to neighboring β-strands with b, 
bw and bs bonds of energies 2ψ , 2ψw  and 2ψs  per bond, respectively. Therefore, the 
frequency k
d
(b,b
w
,b
s
)  of monomer detachment from the fibril periphery can be written 
down as kd (b,bw,bs ) = kref exp(−2bψ − 2bwψw − 2bsψs ) , where refk  is a reference 
frequency. Elimination of 
refk  can be achieved with the aid of the relation kd,kink = ka (0)  
for the equality between the frequency for monomer detachment from a kink site and the 
frequency of monomer attachment at equilibrium. Fibrils with one SH and one WH 
surface, however, have two such kink sites (Figure 5d), with detachment frequencies 
k
d
(1,1, 0)  and k
d
(1, 0,1) , and the work required to remove a monomer from them is 
different. Thus, for the frequency for monomer detachment from a kink site we use the 
geometric average kd,kink = kd (1,1, 0)kd (1, 0,1) = kref exp(−2ψ −ψs −ψw ) . Using this 
equation and Eq. (27) in k
d,kink
= k
a
(0)  leads to kref = ke exp(2ψ +ψw +ψs )  so that the 
general equation for the detachment frequency becomes  
k
d
(b,b
w
,b
s
) = k
e
e
2ψ (1−b)+ψw (1−2bw )+ψs (1−2bs )       (28)  
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The expression for monomer detachment from one of the two strong-bond sides of a 
monomer can then easily be obtained from eq 28 and is  
k
d
(1, 0, 0) = k
e
e
ψw+ψs         (29) 
Using the above expressions for f1, g2, ka, kd in eq 26, yields the general formula for the 
fibril metanucleation rate ( s >ψ
w
+ψ
s
) 
J = f
1
C
1
(1− e
ψs+ψw−s )         (30) 
 Similarly, we can determine J in the nucleation regime by 
J = ( f *−g*)C *         (31) 
where f *  and g*  are the frequencies of monomer attachment and detachment to and 
from the nucleus two kink sites (Figure 5c and 5d), respectively, and C *  is the total 
concentration of nuclei. As before, we set f *= f
1
= 2ka , ka  being given by eq 27. 
Concerning g*= 2kd,eff  
we need to take into account that this frequency depends on the 
nucleus thickness, i.e. the number i ≥1 of β-sheets constituting the nucleus. If the nucleus 
is composed of a 1β-sheet plus one β-strand on its SH side, 
( ) wekkkk eddeffd
ψ
==
2/1
, )1,0,1()0,0,1( is the geometric average of the detachment 
frequencies k
d
(1, 0, 0)
 
from one of the two strong-bond sides of a fibril and the 
detachment frequency k
d
(1, 0,1)
 
of a monomer from the fibril top kink site. Similarly, if 
the nucleus is composed of a 3β-sheet plus one β-strand on its SH surface, 
kd,eff = kd (1, 0, 0)kd (1, 0,1)kd (1,1, 0)kd (1, 0,1)( )
1/4
= kee
ψw /2
 
 is the geometric average of the 
detachment frequencies k
d
(1, 0, 0)
 
from one of the two strong-bond sides of a fibril, 
k
d
(1, 0,1)  from the fibril top kink site, k
d
(1,1, 0)
 
from the fibril bottom kink site, and 
k
d
(1, 0,1)
 
from the fibril top kink site. The general formula of the monomer detachment 
frequency from a nucleus composed of an odd number i =1 , 3, … of β-sheets plus one β-
! 21 
strand on its top SH side is kd,eff = kee
2ψw /(i+1) . Using the above expressions for f*, g*, ka, 
kd,eff in eq 31 yields the corresponding general formula for the fibril nucleation rate 
( i =1,  3,  5...;
 
2ψ
w
/ (i+1)< s < (ψ
s
+ψ
w
) / i ) 
J =C
1
f
1
e
i(s−2ψ )−ψw+ψs
1− e
2ψw /(i+1)[ ]−s
1− e
is− ψw+ψs( )( )
2       (32) 
Analogously, it can be shown that when the nucleus is composed of an odd number i =1, 
3, 5, … of β-sheets plus one β-strand bound to the β-sheet WH side, J is given by 
( i =1,  3,  5,...; ; 2ψ
s
/ (i+1)< s < (ψ
s
+ψ
w
) / i ) 
J =Cf
1
e
i(s−2ψ )−ψs+ψw
1− e
2ψs /(i+1)[ ]−s
1− e
is− ψw+ψs( )( )
2       (33)   
Next, we consider the case when the nucleus is composed of a 2β-sheet plus one β-strand 
on either of its two SH or WH sides. In both cases, 
kd,eff = kd (1, 0, 0)kd (1,1, 0)kd (1, 0,1( )
1/3
= kee
(ψw+ψs )/2 , and the general formula for the effective 
monomer detachment frequency from nuclei is kd,eff = kee
(ψw+ψs )/(i+1) . Using the above 
expressions for f*, g*, ka, kd,eff in eq 31, yields the general formula for the fibril nucleation 
rate  ( i = 2,  4,  6,  ...;
 
(ψ
s
+ψ
w
) / (i+1)< s < 2ψ
w
/ i ) 
J = 2C
1
f
1
e
i(s−2ψ ) 1− e
(ψs+ψw )/(i+1)[ ]−s
1− e
is−2ψw( )
2       (34)   
when the fibril nucleus is composed of an even number i of β-sheets plus one β-strand on 
either of its two WH sides, or by  ( i = 2,  4,  6,  ...;
 
(ψ
s
+ψ
w
) / (i+1)< s < 2ψ
s
/ i ) 
J = 2C
1
f
1
e
i(s−2ψ ) 1− e
(ψs+ψw )/(i+1)[ ]−s
1− e
is−2ψs( )
2       (35)   
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when the β-strand is on either of its two SH sides. Equations 30 and 32-35 are the central 
result of the present study. 
Figure 3 shows the dependence of the fibril nucleation rate J on supersaturation s 
obtained from Equations 30, 32-35 with c
s
= c
w
= 0  at ψ =10 , ψ
s
=1 for asymmetry 
ratios ψ
w
/ψ
s
=1, 0.7, 0.1 (as indicated). As shown in section Fibril Solubility, for the 
symmetric case, ψ
w
/ψ
s
=1, the coexistence supersaturations for the fibrils of thickness 
i =1, 2, 3, and 4 are given by s
iβ = 2 , 1, 2/3, and 1/2, respectively. As indicated in Figure 
3a, the rate J  (Equation 30) in the  s > s
1β  range (range i = 0  in the figure) corresponds to 
the metanucleation regime in which each β-strand in the solution acts as a fibril nucleus. 
In the nucleation regime, J from Equations 32-35 are identical and exhibit jumps at the 
transition supersaturations s
iβ = 2 , 1, 2/3, and 1/2. This is so, because at these 
supersaturations the nucleus changes from e.g. a monomer to a 1β-sheet plus one β-strand 
at the nucleation/metanucleation border s
1β = 2 , or in general from an iβ-sheet plus one β-
strand to an (i+1)β-sheet plus one β-strand at s
iβ . 
For the weakly asymmetric case, ψ
w
/ψ
s
= 0.7 , as shown in section Fibril 
Solubility, there exists a hierarchy of the coexistence supersaturations, 
s
4βw < s4βs < s3β < s2βw < s2βs < s1β , such that iβ-sheets are more soluble than (i+1)β-sheets. 
In the metanucleation range, s > s
1β =1.7 , the nucleation rate J is again described by 
Equation 30. In the s
2βs < s < s1β  
range (orange area in Figure 3b), when the fibril nucleus 
is either a 1β-sheet plus one β-strand attached to the β-sheet either WH or SH side, J is 
described by Equations 32 and 33, respectively. In this supersaturation range the 
difference between the two rates is small, mainly because the work to form the 
corresponding fibril nuclei is similar. The situation changes in the s
2βw < s < s2βs range 
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(yellow area in Figure 3b), because in this range the fibril nuclei are 1β-sheets plus one β-
strand attached to their SH side and 2β-sheets with two WH surfaces plus one β-strand 
attached to either surface. For the former, J is described by Equation 32, and is many 
orders of magnitude higher than J for the latter (described by Equation 34). In the 
s
3β < s < s2βw  
range (green area in Figure 3b), the fibril nuclei are 2β-sheets plus one β-
strand attached to either one of the two WH or SH sides, and J is described by Equations 
34 and 35, respectively. In this supersaturation range the difference between the two rates 
is small again, because the work to form the two different types of nuclei is similar. In the 
s
4βs < s < s3β  
range (brown area in Figure 3b), J is again described by Equations 32 and 
33, as in the s
2βs < s < s1β  range, and the difference between J for fibrils with two either 
WH or SH sides becomes large again.  
The strongly asymmetric case, ψ
w
/ψ
s
= 0.1 , is analogous to the weakly 
asymmetric case for supersaturations s > s
3β (the yellow, orange and white areas in Figure 
3c). The main effect of increasing the hydrophobicity asymmetry is that the nucleation 
rate J resulting from a fibril nucleus composed of a 1β-sheet plus one β-strand attached to 
the SH side is orders of magnitude higher than that of fibrils where the fibril nucleus is a 
1β-sheet plus one β-strand attached to the WH side or a 2β-sheet with two WH surfaces 
plus one β-strand attached to either surface. In the s
2βw < s < s3β  range (green area in the 
Figure 3c), as discussed in section Fibril Solubility, the fibril nuclei are composed of a 1β-
sheet plus one β-strand attached to the SH side and a 3β-sheet plus one β-strand attached 
to the SH side. In this s range, the nucleation rate J resulting from a fibril nucleus 
composed of a 1β-sheet plus one β-strand attached to the SH side is orders of magnitude 
higher than the one due to nuclei with the shape of a 3β-sheet plus one β-strand attached 
to the SH side. The prediction of J quantifies our previous suggestion in section 
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Nucleation Work (Figure 2c), that in a protein solution with strongly asymmetric 
hydrophobicity of β-strands, over a wide supersaturation range (the green and yellow 
areas in Figure 3c), preferably 2β-sheets with WH surfaces nucleate and grow. 
Finally, we note that, experimentally, it is not possible to directly measure 
nucleation rates for fibrils with different structures, but rather the overall nucleation rate. 
For example in the case illustrated in Figure 3b, in the orange range, it is not possible to 
directly measure the nucleation rate resulting from 2β-sheets with two WH surfaces and 
to distinguish it from that due to 2β-sheets with two SH ones. Instead, the overall 
nucleation rate Jtot is measured which is the sum of the two rates. In order to illustrate the 
main effect of increasing the hydrophobicity asymmetry we compare in Figure 6 the s 
dependence of Jtot obtained in each supersaturation regime with cs = cw = 0  at ψ =10 , 
ψ
s
=1and ψ
w
/ψ
s
=1, 0.7, 0.1 (as indicated). The main effect is that lowering ψ
w
 can 
increase the overall nucleation rate by many orders of magnitude at a given s value. As 
can be seen in the Figure, in particular in the low supersaturation range, 0.1< s < 0.7 , 
whereas Jtot for the symmetric and weakly asymmetric case is practically zero, for the 
strongly asymmetric case Jtot is high enough such that it can be detected experimentally. 
As we have found in a previous work
14
, the main reason for this is the dependence of the 
threshold supersaturation s
1β = e
ψ
w
+ψ
s   at the nucleation/metanucleation border on both ψ
s
 
and ψ
w
. Thus, at a given ψ
s
value, lowering ψ
w
shifts s
1β  to lower values thereby 
narrowing the nucleation range and broadening the metanucleation one. Furthermore, in 
this figure we also show the predictions of the dominating J in each supersaturation range 
(red lines in Figures 3b and 3c) showing that they are almost identical to Jtot.  
In order to illustrate and understand the practical implications of the effect of 
asymmetric hydrophobicity of the β-sheet surfaces, in the next section we apply the 
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developed formulas to a model peptide system, and predict absolute values for the fibril 
nucleation rate. 
 
Application to a model peptide system. Experiments on protein aggregation are 
often performed at fixed temperature T. Then the supersaturation can be controlled by the 
monomer protein concentration C
1
, because
11 
s = ln(C
1
/C
e
)          (36) 
where C
e
 is the fibril solubility. This enables us to derive formulas for the C
1
 dependence 
of the nucleation rate J. Using eq (36) in eq (27), and combining it with the relation 
f
1
= 2ka , yields the monomer attachment frequency f1 = 2keC1 /Ce  
as a function of C
1
. 
Then the C
1
 dependence of the metanucleation rate obtained from eq 30 is (C
1
>C
e
e
ψ
w
+ψ
s ) 
J = A
1
C
1
2
(1− A
2
C
1
−1
)          (37) 
where A
1
= 2k
e
/C
e
 and A
2
=C
e
e
ψw+ψs . 
Similarly, we obtain the formula for J in the nucleation regime when the fibril 
nuclei are composed of an odd number i of β-sheets plus one β-strand 
( i =1,  3,  5,  ...;  C
e
e
2ψ
w
/(i+1)
<C1 <Cee
(ψ
w
+ψ
s
)/i
 or C
e
e
2ψ
s
/(i+1)
<C1 <Cee
(ψ
w
+ψ
s
)/i ): 
J = A
1
C
1
i+2 1− A2C1
−1
1− A
3
C
1
i( )
2         (38) 
Here A
1
= (2k
e
/C
e
i+1
)e
−2ψi−ψw+ψs  or A
1
= (2k
e
/C
e
i+1
)e
−2ψi−ψs+ψw  when the β-strand is on the 
nucleus SH or WH side, respectively, and A2 and A3 are given by A2 =Cee
2ψw /(i+1)
 
and 
A
3
=C
e
−i
e
−(ψw+ψs )  in both cases.  
Furthermore, when the fibril nuclei are composed of an even number i of β-sheets plus 
one β-strand, the fibril nucleation rate is given again by eq (38), but with  ... ,6 ,4 ,2=i , 
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C
e
e
(ψ
w
+ψ
s
)/(i+1)
<C
1
<C
e
e
2ψ
w
/i or C
e
e
(ψ
w
+ψ
s
)/(i+1)
<C
1
<C
e
e
2ψ
s
/i ,  A
1
= (4k
e
/C
e
i+1
)e
−2ψi  and 
A
2
=C
e
e
(ψw+ψs )/(i+1) . As to the constant A3, it is different when the β-strand is on one of the 
nucleus two WH or SH sides:
 
A
3
=C
e
−i
e
−2ψw  or A
3
=C
e
−i
e
−2ψs  in the former or the latter 
case, respectively. 
Equations 37 and 38 are also a central result in the present study, and in the 
following we apply them to a model peptide system. The peptides are composed of 10 
amino acids that can arrange in their fully extended conformation as β-strands in a 
nanosized amyloid fibril (protofilament) of successively layered β-sheets with alternating 
WH and SH surfaces (Figure 1). The β-strand length is approximately d
0
= 0.4  nm (e.g. 
ref.
7
), the known value for the distance between the β-strands in a β-sheet is d
h
= 0.5  nm 
(e.g. ref.
7
), and the intersheet distance in the fibril is d =1  nm. Taking these values 
together with σ = 20  mJ/m
-2
 (estimated value, ref.
25
) and σ
s
= 4  mJ/m
-2
 (e.g. ref.
26
), it 
follows from eqs 1 and 2 that ψ =19 , ψ
s
=1.9 , and ψ /ψ
s
=10  for this model peptide at 
T = 300  K. Importantly, as the binding energy of β-strands within the fibrils is different 
for each ψ
w
=1.9 , 1.33 and 0.19 corresponding to asymmetry ratios  ψ
w
/ψ
s
=1,  0.7, and 
0.1, respectively, we expect that the fibril solubility C
e
 is different. As the effect of 
asymmetry of the two hydrophobic β-sheet surfaces on C
e
 has not been determined 
experimentally, we estimate it theoretically by making use of the van’t Hoff equation and 
the Haas-Drenth lattice model for protein crystals.
27
 The integrated van’t Hoff equation is 
given by C
e
=C
r
e
−λ  where C
r  
is a practically temperature independent reference 
concentration and λ = L / kT is the dimensionless latent heat of peptide aggregation into 
β-sheets. Here L is the latent heat of peptide aggregation into such aggregates. In the 
Haas-Drenth lattice model for protein crystals λ is half the binding energy of peptides in 
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the aggregates, which is equivalent to the broken bond energy λ = 2ψ +ψ
s
+ψ
w
 at the 
periphery of a fibril in the m,i plane. The fibril solubility is then given by  
C
e
=C
r
e
−2ψ−ψ
s
−ψ
w            (39) 
where ψ =ψ
hb
+ c
s
ψ
s
+ c
w
ψ
w
. Assuming that C
e
= 6.0×10
21  m
-3
 (= 10 µM) (e.g. ref 28) for 
fibrils composed of short peptides, and that the coefficients c
s
= c
w
= 0 , we can calculate 
C
r
 to be 8.6×1039  m
-3
. Using this Cr value and ψ =19 , ψs =1.9  in eq 39, the solubilities 
for fibrils with ψ
w
=1.33 , and 0.19 (corresponding to asymmetry ratio 0.7 and 0.1) are 
C
e
=1.1×10
22  m
-3
 (= 18 µM) and C
e
= 3.3×10
22
 
m
-3
 (= 55 µM), respectively. Thus, 
lowering ψ
w
 at constant ψ
s
 shifts C
e
 to higher concentrations. Assuming that k
e
=10
−4  s
-
1
 (e.g. ref 
29
) enables us to calculate the J(C1)  dependence from eq 38, and thus Jtot (C1)  
with c
s
= c
w
= 0 at ψ =19 , ψ
s
=1.9  for ψ
w
=1.9 , 1.33, 0.19 (Figure 7a). The 
characteristic feature of the J
tot
(C
1
)  dependence is the sharp rise (10 orders of magnitude) 
at the nucleation/metanucleation border over a very narrow concentration range. Below 
this threshold concentration, fibrils can be nucleated within a day only in volumes of 1 
mm
3
 or larger, used in in vitro experiments. In volumes of about 1 µm3 or smaller, 
comparable to that of biological cells, the fibril nucleation rate is practically negligible 
(less than 1 nucleus per year). This illustrates the important role of the threshold 
concentration C
1β  
in amyloid fibril nucleation, and by combining eq 11 with eq 36 it is 
given by  
C
1β =Cee
ψ
s
+ψ
w          (40) 
Combining eqs 39 and 40 shows that the threshold concentration C
1β  does not change 
when lowering ψ
w
 at constant ψ
s
, because the shift of C
e
 to higher concentrations 
compensates the shift of C
1β  lower ones. 
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The important role of the fibril solubility in amyloid fibril nucleation can be 
further illustrated when we consider that the binding energy in direction of the fibril axis 
is a combination of hydrogen bonding energy and the hydrophobic energies, i.e 
ψ =ψ
hb
+ (ψ
s
+ψ
w
) / 2  where we set c
s
= c
w
= 0.5 . Using again that ψ =19 ,ψ
s
=1.9  for 
this model peptide at T = 300  K, and considering that for the symmetric case ψ
w
=1.9 , 
we calculate that ψ
hb
=17.1 . Thus, the ψ
 
values with c
s
= c
w
= 0.5  at ψ
hb
=17.1 , ψ
s
=1.9
 
for ψ
w
=1.33  and 0.19 (corresponding to asymmetry ratio 0.7 and 0.1) are ψ =18.7  and 
ψ =18.2 , respectively. Assuming that C
e
= 6.0×10
21  m
-3
 (= 10 µM) (e.g. ref 28) for fibrils 
composed of short peptides, we calculate from eq 39 that C
r
= 8.6×10
39  m
-3
 as above. 
Substituting this Cr value in eq 39, the solubilities for such fibrils with ψw =1.33  and 0.19 
(corresponding to asymmetry ratio 0.7 and 0.1) are C
e
=1.9×10
22  m
-3
 (= 31 µM) and 
C
e
=1.8×10
23
 
m
-3
 (= 306 µM), respectively. Thus, considering the contribution of 
hydrophobicity to ψ
 
when lowering ψ
w
 shifts C
e
 to substantially higher concentrations 
as when they are neglected. With k
e
=10
−4  s
-1
 (e.g. ref 
29
) we again calculate the J(C1)  
dependence from eq 38, and thus J
tot
(C
1
)  with c
s
= c
w
= 0.5  for asymmetry ratios 
ψ
w
/ψ
s
=1, 0.7, 0.1 (Figure 7b). As can be seen from this figure, the main effect of 
increasing the asymmetry (decreasing ψ
w
 at constant ψ
s
) is to shift C
1β  to higher 
concentration and to hamper protein fibrillation, because metanucleation commences at 
higher C
1
 values. Using the Ce values calculated above in eq 40, the threshold 
concentrations for fibrils with asymmetry ratios ψ
w
/ψ
s
=1 , 0.7 and 0.1 are 
C
1β = 2.7×10
23  m
-3
 (= 45 µM), C
1β = 4.8×10
23  m
-3
 (= 0.79 mM) and C
1β =1.5×10
24
 
m
-3
 
(= 2.47 mM), respectively.  
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The central result of this discussion is that increasing the hydrophobicity 
asymmetry (decreasing ψ
w
 at constant ψ
s
) can shift C
1β  to higher concentrations thereby 
hampering protein fibrillation, because metanucleation commences at higher C
1
 values. 
This effect is entirely due to the effect of asymmetry of the two hydrophobic β-sheet 
surfaces on the fibril solubility, because it shift C
e
 to higher concentrations. This effect 
becomes more pronounced if we consider that the binding energy in direction of the fibril 
axis is a combination of hydrogen bonding energy and the hydrophobic energies. 
  
CONCLUSIONS  
 
In this study we provide insight into the thermodynamics and kinetics of the direct 
polymerization of peptides into nanofibrils composed of successively layered β-sheets 
with alternating WH and SH surfaces.  
Analysis of the work w for fibril formation reveals that an n-sized nanofibril can 
from by two polymerization pathways. Along the first pathway, a 1β-sheet forms first, 
which then changes its shape to that of a 2β-sheet with two SH surfaces, which then 
changes its shape to a 3β-sheet with one WH and one SH surface, and then transforms 
into a 4 β-sheet with two SH surfaces. This process continues in the same way during the 
further fibril thickening. Along the second pathway, the 1β-sheet changes its shape to that 
of a 2β-sheet with two WH surfaces, which changes its shape to a 3β-sheet with one WH 
and one SH surface, and then transforms into a 4 β-sheet with two WH surfaces. As the 
surface tension of fibrils with two WH surfaces is lower than that of fibrils with two SH 
surfaces, the corresponding nucleation work w* is lower and the fibrils preferably 
nucleate along the second pathway. The larger the asymmetry of the surface energies of 
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the two hydrophobic surfaces (i.e. the smaller the ratio ψ
w
/ψ
s
), the less likely it is that 
fibrils form by the first pathway. 
Regarding the thermodynamics, analysis of the work w for fibril formation 
provides expressions for the threshold supersaturations s
iβ  above which iβ-sheets can 
elongate irreversibly. This analysis shows that there exists a threshold hydrophobicity 
asymmetry ratio ψ
w
/ψ
s
= 0.5  above which the hierarchy of the coexistence 
supersaturations is such that thicker iβ-sheets are less soluble than thinner ones (i.e. 
s
3β < s2βw < s2βs < s1β ). In contrast, below this threshold ratio this hierarchy becomes 
distorted, such that thicker iβ-sheets can be more soluble than thinner ones. In particular, 
we show that s
2βw < s3β < s4βs < s2βs < s1β  at ψw /ψs = 0.1 , implying that a 2β-sheet with 
two WH surfaces is less soluble than a 3β-sheet with one WH and one SH surface and a 
4β-sheet with two SH surfaces. Importantly, the order of the threshold supersaturations 
s
iβ  
determines the type of fibril nuclei in a given s range. For example, in the range 
s
2βs < s < s1β  the 1β-sheet tends to dissolve whereas a 2β-sheet with two WH surfaces can 
irreversibly elongate, and we found that the 1β-sheet plus one β-strand attached to the 
sheet either WH or SH surface is the fibril nucleus.  
In each of the supersaturation ranges, there exists an equilibrium concentration 
C
m
t
*
 
of nuclei with a broad distribution of transition lengths m
t
 at which an iβ-sheet 
transforms into an (i+1)β-sheet. In the example above, the 1β-sheet can transform into a 
2β-sheet at any transition length m
t
. Such a distribution is in contrast to classical 
nucleation theory, which assumes that the nucleus has a uniquely defined size. Due to the 
asymmetry of the surface energies of the two hydrophobic surfaces there exist two such 
distribution functions in a given s range. As the nucleation work w* of fibrils with two 
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WH surfaces is less than that of fibrils with two SH surfaces, the concentration of the first 
kind of fibril nuclei in the protein solution is much higher than that of the second kind of 
nuclei. 
Regarding the kinetics of fibril formation, we obtain general formulas for the J(s)
 
dependence given by eqs 30 and 32 to 35. In each s range there exist two nucleation rates 
that are due to the fact that fibrils can nucleate by the two pathways described above. A 
comparison between the J(s)
 
dependences of fibrils that nucleate along the first and the 
second pathways, and the overall nucleation rate J
tot
 (the sum of the two rates) shows that 
Jtot is almost identical to J for the second pathway over the whole supersaturation range. 
So, kinetically, there is a segregation (or morphological selection) between the two types 
of fibrils, and only one type is relevant. The characteristic feature of the J
tot
(s)  
dependence is a sharp drop at the nucleation/metanucleation border. We show that the 
main effect of increasing the hydrophobicity asymmetry, i.e. of lowering ψ
w
 at a given 
ψ
s
value, is a shift of s
1β  to lower s values and, thereby, a stimulation of protein 
fibrillation. However, application of our considerations to a model peptide system (and to 
derivation of a general formula for the J(C
1
)
 
dependence, eq 38) shows that increasing 
the hydrophobicity asymmetry (decreasing ψ
w
 at constant ψ
s
) can shift C
1β  to higher 
concentrations and to hamper protein fibrillation, because metanucleation commences at 
higher C
1
 values. This effect is entirely due to the effect of asymmetry of the two 
hydrophobic β-sheet surfaces on the fibril solubility, because it shifts C
e
 to higher 
concentrations. This effect becomes more pronounced if we consider that the binding 
energy in direction of the fibril axis is a combination of hydrogen bonding energy and the 
hydrophobic energies. 
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Finally, we emphasize that the results obtained above apply to one-step fibril 
nucleation, i.e when the monomeric proteins polymerize directly into fibrils, and that the 
analysis treats homogeneous nucleation of amyloid fibrils occurring when nucleation-
active foreign particles or substrates are absent from the solution. The derived general 
expressions for the fibril nucleation rate J as an explicit function of the supersaturation are 
a step towards first-principle predictions of fibril nucleation rates based on the amino acid 
sequence of the proteins. The application to specific protein systems, however, requires 
knowledge of the fibrils structure, the fibril solubility, the broken bond energies of amino 
acids (or alternatively the surface tensions of the fibril lengthening and thickening axis). It 
should be mentioned that entropic effects such as the loss of entropy when a β-strand is 
attached to the fibril or the entropy due to vibrations of the β-strand within fibrils are not 
explicitly considered. However, entropic effects on the fibril solubility and entropic 
contributions to the broken bond energies are automatically accounted for when 
experimental data for Ce and ψ, ψh are used.  
The results obtained in this study highlight the importance of the fibril solubility in 
amyloid fibril nucleation. Currently, the focus of experimental studies on amyloids is 
mostly on their structure, assembly mechanism and their interactions with the biological 
environment. Not so many experiments focus on determining the fibril solubility and how 
it changes with the fibril structure and amino acid sequence. Similarly, computational and 
theoretical studies of amyloid focus less on determining the fibril solubility and a better 
understanding is urgently needed. Nevertheless, the analysis made offers answers to the 
fundamental question of the effect of asymmetry between the weak and strong 
hydrophobic β-sheet surfaces on the thermodynamics and kinetics of the polymerization 
process, which could be a helpful guide in studying the intriguing phenomenon of 
amyloid fibril nucleation. 
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Figure 1. Schematic of nanosized amyloid fibril (protofilament) with thickness of i β-
sheets and length of m  β-strands. The σ ’s are the specific surface energies of the fibril 
surfaces, and the a’s are the areas of the β-strand faces. The red and blue areas indicate 
the β-sheet SH and WH surfaces, respectively. In our model we assume that for a 1β-
sheet the SH surface is always on top (indicated by the red line) whereas the WH surface 
is at the bottom (indicated by the blue line). In addition, a β-strand can only bind itself to 
a WH β-sheet surface with its WH side (blue binds to blue) and to an SH β-sheet surface 
with its SH side (red binds to red). Thus, the hydrophobicity of the surface of a nanofibril 
alternates with increasing number of β-sheets (red, blue, red, blue, etc.). 
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Figure 2. Work w for nanofibril formation as a function of the nanofibril size n with 
c
s
= c
w
= 0  at ψ =10 and ψ
s
=1 . In panel (a) ψ
w
/ψ
s
=1 (symmetric hydrophobicity) at 
s /ψ
s
= 0.7 , in panel (b) ψ
w
/ψ
s
= 0.7  (weakly asymmetric hydrophobicity) at 
s /ψ
s
= 0.6 , and in panel (c) ψ
w
/ψ
s
= 0.1  (strongly asymmetric hydrophobicity) at 
s /ψ
s
= 0.12 . The transition sizes n
t
=12 , 64, 144, 240 are the same for all three ψ
w
/ψ
s
 
ratios (as indicated). Successive nanofibril shapes are schematically shown to visualize 
the nanofibril transitions from 1β- to 2β-sheet, from 2β- to 3β-sheet, and so on. The 
smallest rectangle represents a single β-strand and it is shown in red when it binds itself to 
an SH β-sheet surface and in blue when it binds itself to a WH one. The red and blue lines 
correspond to the formation work w of nanofibrils that form along a low- and high-energy 
pathway,respectively. 
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Figure 3. Rate J of fibril nucleation as a function of the supersaturation s with c
s
= c
w
= 0  
at ψ =10 , ψ
s
=1
 
for ψ
w
/ψ
s
=1  (panel a), ψ
w
/ψ
s
= 0.7  (panel b), and ψ
w
/ψ
s
= 0.1  
(panel c). Shapes of the fibril nuclei are schematically shown in the different 
supersaturation ranges indicated by the white, orange, yellow, green, brown, and grey 
areas. The red and blue lines correspond to the nucleation rates obtained for fibril nuclei 
with a β-strand attached on the nucleus SH (red monomer) or WH (blue monomer) sides, 
respectively. 
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Figure 4. Length distribution of fibril nuclei with thickness of one β-sheet: lines 1.2 and 
1.6 are at s /ψ
s
=1.2  and 1.6, respectively, i =1, ψ =10 , ψ
s
=1  and ψ
w
= 0.7 . The red 
and blue lines correspond to fibril nuclei with a β-strand on the SH (red) or WH (blue) 
side of the β-sheet, respectively. 
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Figure 5. Schematic illustration of the monomer attachment and detachment frequencies 
k
a
, k
d
 and k
d,kink
. The red and blue monomers indicate the attachment to the fibril SH and 
WH side, respectively. The pluses indicate the nanofibril kink sites.  
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Figure 6. Overall nucleation rate Jtot for fibril formation as a function of the 
supersaturation s with c
s
= c
w
= 0  at ψ =10 , ψ
s
=1  for ψ
w
=1 , 0.7, 0.1 corresponding to 
asymmetry ratios ψ
w
/ψ
s
=1, 0.7, 0.1 (as indicated). The black and red lines indicate the 
rate in the metanucleation and nucleation regimes, respectively. The dotted green line 
indicate the highest rate from eq 38 in the corresponding s range (red lines from Figure 3b 
and 3c).  
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Figure 7. (a) Concentration dependence of the overall nucleation rate Jtot for the model 
peptide system with c
s
= c
w
= 0  at ψ =19 , ψ
s
=1.9  for ψ
w
=1.9  (black line), 1.33 (red 
line), 0.19 (blue line) corresponding to asymmetry ratios ψ
w
/ψ
s
=1 , 0.7, 0.1. (b) 
Concentration dependence of the overall nucleation rate Jtot for the model peptide system 
with c
s
= c
w
= 0.5  at ψ =19 , ψ
s
=1.9  for ψ
w
=1.9  (asymmetry ratio ψ
w
/ψ
s
=1 ), at 
ψ =18.72 , ψ
s
=1.9  for ψ
w
=1.33  (asymmetry ratio ψ
w
/ψ
s
= 0.7 ), and at ψ =18.15 , 
ψ
s
=1.9  for ψ
w
= 0.19  (asymmetry ratio ψ
w
/ψ
s
= 0.1 ), as indicated. The black and red 
lines indicate the rate in the metanucleation and nucleation regimes, respectively. 
 
 
